Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Eupraxia Pharmaceuticals (EPRX)

Annual Return

Over the past 3 years, EPRX has had an average annual return of +1.23%, underperforming the benchmark SPY, which returned +19.63% annual.

Since Aug 3, 2021, EPRX has had an average annual return of +18.13%, outperforming the benchmark SPY, which returned +12.75% annual.

202620252024202320222021
-15.50%+138.18%-23.82%+54.69%+16.95%-17.53%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+9.67%-1.21%-11.49%+7.74%-9.10%-6.77%-3.48%-15.50%
2025-8.65%+39.85%-19.01%+25.01%-5.37%+48.45%-6.25%-0.74%+10.08%-6.10%+12.09%+21.58%+138.18%
2024-8.92%+32.19%-35.33%-15.43%-1.09%-4.80%+10.07%-10.21%+3.14%-4.94%+33.99%-5.37%-23.82%
2023+17.10%-4.75%-2.01%+57.54%+7.96%+25.88%-12.30%+0%+0%-28.29%+0%+5.13%+54.69%
2022+0%+0%+0%+0%-43.92%-33.97%+0%+0%+0%+251.05%+1%-10.93%+16.95%
2021+0%-22.40%+3.96%+2.23%+0%-17.53%

Drawdown analysis of Eupraxia Pharmaceuticals (EPRX)

The maximum drawdown for the EPRX was -69.46%, occurring on Jun 27, 2022. Recovery took 88 trading sessions.

The current EPRX drawdown is -29.66%.

Since Aug 3, 2021 EPRX has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 3 times
  • 20% or more: 3 times
  • 10% or more: 5 times
DepthStartTo BottomBottomTo RecoverEndTotal
-69.46%Aug 3, 2021226Jun 27, 202288Oct 31, 2022314
-66.06%Jul 5, 2023318Oct 8, 2024302Dec 22, 2025620
-34.73%Feb 3, 202688Jun 10, 2026OngoingOngoingOngoing
-18.73%Nov 3, 202239Dec 30, 202270Apr 13, 2023109
-12.73%Jan 21, 20268Feb 2, 20261Feb 3, 20269
-7.40%May 23, 20234May 30, 202310Jun 13, 202314
-6.90%Jun 13, 20236Jun 22, 20235Jun 29, 202311
-6.73%Dec 29, 20256Jan 7, 20261Jan 8, 20267
-6.08%Apr 27, 20234May 3, 20237May 12, 202311
-5.50%Apr 17, 20232Apr 19, 20235Apr 27, 20237
-5.47%Jan 8, 20261Jan 9, 20264Jan 15, 20265
-4.35%May 12, 20236May 22, 20231May 23, 20237
-0.23%Jan 15, 20261Jan 16, 20261Jan 20, 20262